https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-04-01 / Int. J. Oncol. 2008 Apr;32(4):777-89
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-04-01 / Int. J. Oncol. 2008 Apr;32(4):777-892008-04-01 00:00:002021-11-15 17:05:15An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-13 / Cancer Immunol. Immunother. 2008 Sep;57(9):1421-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-13 / Cancer Immunol. Immunother. 2008 Sep;57(9):1421-72008-02-13 00:00:002021-11-15 17:05:45Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-15 / J. Neurooncol. 2007 Sep;84(2):131-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-15 / J. Neurooncol. 2007 Sep;84(2):131-402007-03-15 00:00:002021-11-15 15:39:28Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / Neurosurgery 2006 Nov;59(5):988-99; discussioin 999-1000
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / Neurosurgery 2006 Nov;59(5):988-99; discussioin 999-10002006-11-01 00:00:002021-11-15 15:39:05Dendritic cell vaccination in patients with malignant gliomas: current status and future directions
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-11-01 / Br. J. Cancer 2004 Nov;91(9):1656-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-11-01 / Br. J. Cancer 2004 Nov;91(9):1656-622004-11-01 00:00:002021-11-15 15:38:39Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-05-01 / J. Neurosurg. 2004 May;100(5 Suppl Pediatrics):492-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-05-01 / J. Neurosurg. 2004 May;100(5 Suppl Pediatrics):492-72004-05-01 00:00:002021-11-15 15:38:16Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2002-12-12 18:49:432019-02-12 18:50:31Editorial von Prof. Dr. Volker Schirrmacher zum Beitrag „Immuntherapeutische Strategien zur Behandlung solider Tumoren“
